Targeting EZH2 in Cancer: Mechanisms, Pathways, and Therapeutic Potential
Enhancer of zeste homolog 2 (EZH2) is a methyltransferase involved in cell cycle regulation, cell differentiation, and cell death and plays a role in modulating the immune response. Although it mainly functions by catalyzing the tri-methylation of H3 histone on K27 (H3K27), to inhibit the transcript...
Saved in:
| Main Authors: | Maria Saveria Gilardini Montani, Rossella Benedetti, Mara Cirone |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Molecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1420-3049/29/24/5817 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The epigenetic role of EZH2 in acute myeloid leukemia
by: Jinyong Fang, et al.
Published: (2024-12-01) -
EZH2 expression in colorectal carcinoma: an evaluation of clinicopathological and prognostic value
by: Diren Vuslat Cagatay, et al.
Published: (2025-06-01) -
Impairment of regulatory T cell stability in axial spondyloarthritis: role of EZH2 and pSTAT5
by: Majda Lyna Mebrek, et al.
Published: (2024-11-01) -
Multi-Faceted Role of Histone Methyltransferase Enhancer of Zeste 2 (EZH2) in Neuroinflammation and Emerging Targeting Options
by: Sotirios Moraitis, et al.
Published: (2025-06-01) -
EZH-2 expression and prognostic significance in patients with low-grade non-Hodgkin lymphoma
by: Meryem Şener, et al.
Published: (2025-06-01)